226
Views
15
CrossRef citations to date
0
Altmetric
Research Articles

Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats

, , &
Pages 140-146 | Received 07 Dec 2013, Accepted 02 Apr 2014, Published online: 27 May 2014

References

  • Frantseva MV, Carlen PL, Perez Velazquez JL. Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Radic Biol Med 2001;31(10):1216–27.
  • Kamada H, Nito C, Endo H, Chan PH. Bad as a converging signaling molecule between survival PI3-K/Akt and death JNK in neurons after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2007;27(3):521–33.
  • Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20(1):84–91.
  • HE M, GUO Q. Cerebral protection of trichostatin: a preconditioning in rats with middle cerebral artery occlusion and the relationship between trichostatin A and IL-1β. J Cent South Univ (Med Sci). 2012;37(4):379–83.
  • Kim HJ, Rowe M, Ren M, Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007;321(3): 892–901.
  • Belayev L, Alonso OF, Busto R, Middle cerebral artery occlusion in the rat by intraluminal suture neurological and pathological evaluation of an improved model. Stroke 1996;27(9):1616–23.
  • Leoni F, Zaliani A, Bertolini G, The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci 2002;99(5):2995–3000.
  • Chakravortty D, Koide N, Kato Y, The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J Endotoxin Res 2000;6(3):243–7.
  • Kim HJ, Rowe M, Ren M, Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007;321(3):892–901.
  • Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today 2005;10(3):197–204.
  • Yin L, Laevsky G, Giardina C. Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J Biol Chem 2001;276(48):44641–6.
  • Takada Y, Gillenwater A, Ichikawa H, Aggarwal BB. Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-κB activation. J Biol Chem 2006;281(9): 5612–22.
  • Yu Z, Zhang W, Kone BC. Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol 2002;13(8):2009–17.
  • Klampfer L, Huang J, Swaby LA, Augenlicht L. Requirement of histone deacetylase activity for signaling by STAT1. J Biol Chem 2004;279(29):30358–68.
  • Adcock I. HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 2007;150(7):829.
  • Ryu H, Lee J, Olofsson BA, Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci 2003;100(7):4281–6.
  • Chen G, Zeng WZ, Yuan PX, The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999;72(2):879–82.
  • Bown CD, Wang JF, Young LT. Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells. Neuropharmacology 2000;39(11):2162–9.
  • Chuang DM, Hough C, Senatorov VV. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative disease. Annu Rev Pharmacol Toxicol 2005;45: 269–90.
  • Kanai H, Sawa A, Chen R, Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J 2004;4(5):336–44.
  • Fukumoto T, Morinobu S, Okamoto Y, Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 2001;158(1):100–106.
  • Chen PS, Peng GS, Li G, Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 2006;11(12):1116–25.
  • Yoshida M, Matsuyama A, Komatsu Y, Nishino N. From discovery to the coming generation of histone deacetylase inhibitors. Curr Med Chem 2003;10(22):2351–8.
  • Finnin MS, Donigian JR, Cohen A, Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999;401(6749):188–93.
  • Stein A, Tang X, Guo Y, Delayed adaptation of the heart to stress: late preconditioning. Stroke; A Journal of Cerebral Circulation 2004;35(11 Suppl 1):2676–9.
  • Yildirim F, Gertz K, Kronenberg G, Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol 2008;210(2): 531–42.
  • Yu L, Lu M, Wang P, Chen X. Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. Arch Med Res 2012;43(3):190–96.
  • Fleiss B, Nilsson M, Blomgren K, Mallard C. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. J Neuroinflammation 2012;9:70.
  • Camelo S, Iglesias AH, Hwang D, Transcriptional therapy with the histone deacetylase inhibitor trichostatin: a ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 2005;164(1):10–21.
  • Zhou C, Qiu L, Sun Y, Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Int J Oncol 2006;29(1):269–78.
  • Yu Z, Kone BC. Targeted histone H4 acetylation via phosphoinositide 3-kinase-and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. Am J Physiol Renal Physiol 2006;290(2):F496–F502.
  • Zhao H, Shimohata T, Wang JQ, Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005;25(42):9794–806.
  • Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013;38(2):209–23.
  • Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008;9(5):378–90.
  • Datta SR, Dudek H, Tao X, Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91(2):231–41.
  • del Peso L, González-García M, Page C, Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278(5338):687–9.
  • Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-κB by the Akt/PKB kinase. Current Biology 1999;9(11):601–4.
  • Ozes ON, Mayo LD, Gustin JA, NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase. Nature 1999;401(6748):82–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.